SG44192G - 1-benzyl-aminoalkyl-pyrrolidinones and their addition salts,process for their preparation and pharmaceutical compounds containing them - Google Patents

1-benzyl-aminoalkyl-pyrrolidinones and their addition salts,process for their preparation and pharmaceutical compounds containing them

Info

Publication number
SG44192G
SG44192G SG441/92A SG44192A SG44192G SG 44192 G SG44192 G SG 44192G SG 441/92 A SG441/92 A SG 441/92A SG 44192 A SG44192 A SG 44192A SG 44192 G SG44192 G SG 44192G
Authority
SG
Singapore
Prior art keywords
pyrrolidinones
aminoalkyl
benzyl
preparation
addition salts
Prior art date
Application number
SG441/92A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SG44192G publication Critical patent/SG44192G/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
SG441/92A 1983-10-04 1992-04-22 1-benzyl-aminoalkyl-pyrrolidinones and their addition salts,process for their preparation and pharmaceutical compounds containing them SG44192G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833336024 DE3336024A1 (de) 1983-10-04 1983-10-04 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Publications (1)

Publication Number Publication Date
SG44192G true SG44192G (en) 1992-09-04

Family

ID=6210932

Family Applications (1)

Application Number Title Priority Date Filing Date
SG441/92A SG44192G (en) 1983-10-04 1992-04-22 1-benzyl-aminoalkyl-pyrrolidinones and their addition salts,process for their preparation and pharmaceutical compounds containing them

Country Status (27)

Country Link
US (4) US4767759A (pl)
EP (1) EP0136658B1 (pl)
JP (2) JPS6094959A (pl)
KR (1) KR910007882B1 (pl)
AR (1) AR243503A1 (pl)
AU (1) AU565839B2 (pl)
CA (1) CA1242193A (pl)
CS (2) CS244148B2 (pl)
DD (1) DD227963A5 (pl)
DE (2) DE3336024A1 (pl)
DK (1) DK164049C (pl)
ES (3) ES536469A0 (pl)
FI (1) FI78464C (pl)
GR (1) GR80546B (pl)
HK (1) HK75892A (pl)
HU (1) HU193229B (pl)
IE (1) IE58155B1 (pl)
IL (1) IL73125A (pl)
NO (1) NO165239C (pl)
NZ (1) NZ209759A (pl)
PH (1) PH23764A (pl)
PL (2) PL145637B1 (pl)
PT (1) PT79306B (pl)
SG (1) SG44192G (pl)
SU (2) SU1373318A3 (pl)
YU (2) YU43858B (pl)
ZA (1) ZA847755B (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
DE3634220A1 (de) * 1986-10-08 1988-04-14 Boehringer Ingelheim Kg Verwendung von 1-benzyl-aminoalkyl-pyrrolidinonen als antidepressiva
DE3706399A1 (de) * 1987-02-27 1988-09-08 Boehringer Ingelheim Kg Mittel mit antidepressiver wirkung
DE3864124D1 (de) * 1987-05-20 1991-09-12 Zambon Spa Isoxazole mit nootropischer wirkung.
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
IE61631B1 (en) * 1988-05-20 1994-11-16 Zambon Spa Compounds with central analgesic activity, process for their preparation and pharmaceutical compositions containing them
CA2007732A1 (en) * 1989-01-17 1990-07-17 Gary L. Olson Cyclohexaneacetamide derivatives
IT1231477B (it) * 1989-07-12 1991-12-07 Sigma Tau Ind Farmaceuti (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
US5066663A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted-hetero-cyclopentanones and cyclopentenones and derivatives thereof acting at muscarinic receptors
JPH083023Y2 (ja) * 1991-05-21 1996-01-29 株式会社四国総合研究所 太陽電池モジュール用架台
US5538985A (en) * 1994-01-27 1996-07-23 Mitsui Toatsu Chemicals, Inc. Pyrrolidinone derivatives
WO1997036900A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
BR9709857A (pt) * 1996-06-21 2002-05-21 Syntroleum Corp processo e sistema de produção de gás de sìntese
PE17599A1 (es) 1996-07-09 1999-02-22 Syntroleum Corp Procedimiento para convertir gases a liquidos
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives
US5950732A (en) * 1997-04-02 1999-09-14 Syntroleum Corporation System and method for hydrate recovery
AU9690298A (en) 1997-10-10 1999-05-03 Syntroleum Corporation System and method for converting light hydrocarbons to heavier hydrocarbons withseparation of water into oxygen and hydrogen
WO2000051607A1 (en) 1999-03-02 2000-09-08 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
US6489354B1 (en) 1999-03-02 2002-12-03 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
AU3389300A (en) 1999-03-02 2000-09-21 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6794417B2 (en) 2002-06-19 2004-09-21 Syntroleum Corporation System and method for treatment of water and disposal of contaminants produced by converting lighter hydrocarbons into heavier hydrocarbon
ATE539077T1 (de) * 2003-09-03 2012-01-15 Pfizer Benzimidazolonverbindungen mit agonistischer wirkung am 5-ht4 rezeptor
GEP20094638B (en) 2004-06-15 2009-03-10 Pfizer Benzimidazolone carboxylic acid derivatives
GR1004905B (el) * 2004-07-14 2005-05-27 Ε.Ι.Ε. (Εθνικο Ιδρυμα Ερευνων) Καινοτομα αντιυπερτασικα προιοντα
FR2940609B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133082A (en) * 1960-06-09 1964-05-12 Mead Johnson & Co 1-substituted-3-pyrrolidylmethylamines
NL136272C (pl) * 1962-07-13
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
BE791606A (fr) * 1972-07-10 1973-03-16 Pilot Pen Co Ltd Procede et appareil pour aspirer et soulever la feuille la plussuperieure d'une pile de feuilles de ce type
JPS5244559A (en) * 1975-10-06 1977-04-07 Ise Electronics Corp Fluorescent display tube with luminescent diode
JPS5346966A (en) * 1976-10-06 1978-04-27 Teijin Ltd Lactamamines and their preparation
JPS5344559A (en) * 1976-10-06 1978-04-21 Teijin Ltd New urethanes and their preparation
FR2387218A1 (fr) * 1977-04-15 1978-11-10 Ile De France Nouveaux n-(1'-ethyl 2'-oxo 5'-pyrrolidinyl methyl) benzamides, leurs procedes de preparation et leur application comme modificateurs du comportement
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE2924011C2 (de) * 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
DE2923975A1 (de) * 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
CH657527A5 (de) * 1980-02-13 1986-09-15 Ciba Geigy Ag Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
FR2549053B1 (fr) * 1983-07-12 1985-12-27 Sanofi Sa Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
US4767759A (en) 1988-08-30
EP0136658A2 (de) 1985-04-10
DE3477922D1 (en) 1989-06-01
ES8601878A1 (es) 1985-11-16
NZ209759A (en) 1989-04-26
PL249852A1 (en) 1985-09-10
CA1242193A (en) 1988-09-20
KR850003393A (ko) 1985-06-17
ES8601877A1 (es) 1985-11-16
ES8505652A1 (es) 1985-06-01
IL73125A0 (en) 1984-12-31
DK474684A (da) 1985-04-05
EP0136658A3 (pl) 1985-06-05
DK164049B (da) 1992-05-04
PL253280A1 (en) 1986-02-11
SU1373318A3 (ru) 1988-02-07
YU43901B (en) 1989-12-31
ES539883A0 (es) 1985-11-16
CS153784A2 (en) 1985-08-15
PT79306B (de) 1986-11-13
NO843979L (no) 1985-04-09
US4996224A (en) 1991-02-26
DK474684D0 (da) 1984-10-03
YU43858B (en) 1989-12-31
CS244148B2 (en) 1986-07-17
JPH046684B2 (pl) 1992-02-06
US5073671A (en) 1991-12-17
PT79306A (de) 1984-11-01
IE842519L (en) 1985-04-04
FI78464B (fi) 1989-04-28
AU565839B2 (en) 1987-10-01
AU3383484A (en) 1985-04-18
NO165239C (no) 1991-01-16
CS410891A3 (en) 1992-08-12
JPS6094959A (ja) 1985-05-28
ZA847755B (en) 1986-06-25
YU199086A (en) 1987-10-31
ES536469A0 (es) 1985-06-01
AR243503A1 (es) 1993-08-31
JPH04261152A (ja) 1992-09-17
NO165239B (no) 1990-10-08
DK164049C (da) 1992-09-28
FI78464C (fi) 1989-08-10
ES539884A0 (es) 1985-11-16
PL145630B1 (en) 1988-10-31
DD227963A5 (de) 1985-10-02
GR80546B (en) 1985-02-05
PL145637B1 (en) 1988-10-31
HUT35641A (en) 1985-07-29
HU193229B (en) 1987-08-28
YU169684A (en) 1987-10-31
JPH0739387B2 (ja) 1995-05-01
IL73125A (en) 1988-10-31
HK75892A (en) 1992-10-09
FI843856L (fi) 1985-04-05
US4833140A (en) 1989-05-23
KR910007882B1 (ko) 1991-10-04
FI843856A0 (fi) 1984-10-02
EP0136658B1 (de) 1989-04-26
SU1306472A3 (ru) 1987-04-23
DE3336024A1 (de) 1985-04-18
IE58155B1 (en) 1993-07-14
PH23764A (en) 1989-11-03

Similar Documents

Publication Publication Date Title
DE3477922D1 (en) -1-benzyl-aminoalkyl-pyrrolidinones and their addition salts, process for their preparation and pharmaceutical compounds containing them
DE3461090D1 (en) 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
MY8700363A (en) 7-amino-1-gyclopropyl-4-oxo-1, 4-dihydronaphthyridine-3-carboxylic acids, process for their preparation and medicaments containing these compounds
ZA847165B (en) Carbonylmethylene-heterocyclic compounds containing trihalogeno-methyl groups,process for their preparation,and light-sensitive mixture containing the compounds
IL72085A (en) 13alpha-alkylgonanes,processes for their preparation and pharmaceutical compositions containing them
EP0133678A3 (en) New cephem compounds, processes for preparation thereof and pharmaceutical compositions containing them
IL80106A0 (en) Arylmethylazoles and their salts,processes for their preparation and pharmaceutical compositions containing them
EP0145121A3 (en) Pyrazoloquinolines, process for their preparation, and pharmaceutical compositions containing them
CS309984A2 (en) Process for preparing pharmaceutical agent
PT78599A (en) Process for preparing benzodiazephin derivatives and pharmaceutical compositions containing them
DE3262870D1 (en) Aminobenzamides, their salts, process for their preparation and pharmaceutical compositions containing them
IL69735A (en) 1-phenyl-1-aminoalkyl-cyclobutane derivatives,process for their preparation and pharmaceutical compositions containing them
GR80474B (en) Chinazolinderivatives, method for the preparation thereof, and medicaments containing said compounds
HUT35638A (en) Process for producing new 16-fluoro-16,17-didehydro-prostaglandines and pharmaceutical compositions containing them
GB2138817B (en) 4-pheny-tetrahydro-furano-pyridines, process for their preparation, and pharmaceutical compositions containing them
ZA841781B (en) Penim compounds,methods for their preparation and pharmaceutical compositions containing them
ZA83567B (en) Diphosphonic acid derivatives, process for their preparation and pharmaceutical preparation containing them
AR242380A1 (es) Procedimiento de preparacion de derivados de piperidinilmetil-fenoxi-aminopropanol-2-
PT78530B (en) Process for preparing heterocyclil-lower alkylpenem and pharmaceutical compositions containing them
DE3372968D1 (en) Heterocyclyl-thio compounds, process for their preparation, pharmaceutical compositions containing them and their use
DE3368046D1 (en) Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
IL69107A (en) 15-hydroxyimino-14-oxo-eburnamenine derivatives,process for their preparation and pharmaceutical compositions containing these compounds
IL69105A0 (en) Apovincaminic acid derivatives,process for their preparation and pharmaceutical compositions containing them
ZA843757B (en) Aminocyclic derivatives,process for preparing these compounds and pharmaceutical compositions thereof
DE3461376D1 (en) N-cyano-formamidine compounds, process for preparing them and pharmaceutical compositions containing them